Jiangsu Hengrui Medicine
600276.SS
#527
Rank
โ‚น3.374 T
Marketcap
โ‚น529.08
Share price
1.17%
Change (1 day)
-0.95%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

ESG Reports

Annual ReportsESG Reports
Thumbnail Jiangsu Hengrui Medicine
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report
Thumbnail Jiangsu Hengrui Medicine
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail Jiangsu Hengrui Medicine
 ESG Report 2021

ESG Report 2021

Language: English

View ESG Report